Free Trial

Sutro Biopharma (STRO) SEC Filings & 10K Form

Sutro Biopharma logo
$0.81 +0.00 (+0.58%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.80 -0.01 (-1.48%)
As of 08/1/2025 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sutro Biopharma SEC Filings

DateFilerForm TypeView
07/29/2025
1:41 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
07/16/2025
6:02 PM
BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G/A
06/30/2025
3:36 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
06/25/2025
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
3:26 PM
Chow Gregory K. (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2025
3:27 PM
Chow Gregory K. (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
10:39 AM
Kynam Capital Management, LP (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
05/08/2025
3:28 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
3:30 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
4:45 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
4:46 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
4:48 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2025
3:30 PM
Sutro Biopharma (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form DEFA14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form ARS
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G/A
04/08/2025
3:03 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/08/2025
3:05 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:07 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:09 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:11 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:12 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:32 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
03/13/2025
4:14 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
4:17 PM
Sutro Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
3:14 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:09 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:12 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:32 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:34 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:40 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:42 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:44 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:57 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:58 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:30 PM
Sutro Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/10/2024
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/04/2024
1:09 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/13/2024
3:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:16 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:38 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
3:40 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STRO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners